Lv41
660 积分 2025-06-05 加入
GPCR drug discovery: new agents, targets and indications
6小时前
已完结
Cloning of the gene and cDNA for mammalian β-adrenergic receptor and homology with rhodopsin
4天前
已完结
Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial
21天前
已完结
Inflammatory Biomarkers in Hypertension
22天前
已完结
Consensus guidelines for the diagnosis and treatment of multiple sclerosis
24天前
已完结
O7 Glucagon and GLP-1 receptor dual agonist survodutide improved liver histology in people with MASH and fibrosis: results from a randomised, double-blind, placebo-controlled phase 2 trial
24天前
已完结
Pathophysiologic mechanisms in diabetic kidney disease: A focus on current and future therapeutic targets
25天前
已完结
FDA approves first GPCR biased agonist
27天前
已完结
GPCR drug discovery: new agents, targets and indications
27天前
已完结
Efficacy of metformin in obese and non-obese women with polycystic ovary syndrome: a randomized, double-blinded, placebo-controlled cross-over trial
1个月前
已完结
A Guide for the Perplexed Physician
2小时前
待审核
Proportional-Assist Ventilation for Minimizing the Duration of Mechanical Ventilation
2小时前
已采纳
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
2小时前
待审核
Medical Management and Revascularization for Asymptomatic Carotid Stenosis
14天前
已采纳
Beyond the Class Effect - Does Beta-Blocker Choice Matter after Myocardial Infarction?
14天前
已采纳
A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide
7个月前
已采纳
Research Summary Neoadjuvant GOLP in Intrahepatic Cholangiocarcinoma
7个月前
已采纳
Research Summary Neoadjuvant GOLP in Intrahepatic Cholangiocarcinoma
7个月前
已驳回
A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide
7个月前
已撤回
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity
7个月前
已采纳
皖公网安备34019202002308
